OBJECTIVES: We identified race-associated differences in survival among HIV-positive US veterans to examine possible etiologies for these differences. METHODS: We used national administrative data to compare survival by race and used data from the Veterans Aging Cohort 3-Site Study (VACS 3) to compare patients' health status, clinical management, and adherence to medication by race. RESULTS: Nationally, minority veterans had higher mortality rates than did white veterans with HIV. Minority veterans had poorer health than white veterans with HIV. No significant differences were found in clinical management or adherence. CONCLUSIONS: HIV-positive minority veterans experience poorer survival than white veterans. This difference may derive from differences in comorbidities and in the severity of illness of HIV-related disease.
OBJECTIVES: We identified race-associated differences in survival among HIV-positive US veterans to examine possible etiologies for these differences. METHODS: We used national administrative data to compare survival by race and used data from the Veterans Aging Cohort 3-Site Study (VACS 3) to compare patients' health status, clinical management, and adherence to medication by race. RESULTS: Nationally, minority veterans had higher mortality rates than did white veterans with HIV. Minority veterans had poorer health than white veterans with HIV. No significant differences were found in clinical management or adherence. CONCLUSIONS: HIV-positive minority veterans experience poorer survival than white veterans. This difference may derive from differences in comorbidities and in the severity of illness of HIV-related disease.
Authors: Nancy D Harada; JoAnn Damron-Rodriguez; Valentine M Villa; Donna L Washington; Shawkat Dhanani; Herbert Shon; Manas Chattopadhyay; Howard Fishbein; Martin Lee; Takashi Makinodan; Ronald Andersen Journal: Med Care Date: 2002-01 Impact factor: 2.983
Authors: Ulrike Boehmer; Nancy R Kressin; Dan R Berlowitz; Cindy L Christiansen; Lewis E Kazis; Judith A Jones Journal: Am J Public Health Date: 2002-09 Impact factor: 9.308
Authors: M F Shapiro; S C Morton; D F McCaffrey; J W Senterfitt; J A Fleishman; J F Perlman; L A Athey; J W Keesey; D P Goldman; S H Berry; S A Bozzette Journal: JAMA Date: 1999 Jun 23-30 Impact factor: 56.272
Authors: Joseph Conigliaro; Jeff Whittle; Chester B Good; Melissa Skanderson; Mary Kelley; Kenneth Goldberg Journal: Med Care Date: 2002-01 Impact factor: 2.983
Authors: Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne Journal: Lancet Date: 2002-07-13 Impact factor: 79.321
Authors: Frank J Palella; Maria Deloria-Knoll; Joan S Chmiel; Anne C Moorman; Kathleen C Wood; Alan E Greenberg; Scott D Holmberg Journal: Ann Intern Med Date: 2003-04-15 Impact factor: 25.391
Authors: Thomas P Giordano; Glenn Bartsch; Yafeng Zhang; Ellen Tedaldi; Judith Absalon; Sharon Mannheimer; Avis Thomas; Rodger D MacArthur Journal: AIDS Patient Care STDS Date: 2010-05 Impact factor: 5.078
Authors: Robert S Levine; Nathaniel C Briggs; Barbara S Kilbourne; William D King; Yvonne Fry-Johnson; Peter T Baltrus; Baqar A Husaini; George S Rust Journal: Am J Public Health Date: 2007-08-29 Impact factor: 9.308